Ovid Therapeutics Inc. (OVID) Earnings
|
Expand Research on OVID
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +18.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/16/26  |
Q425 | N/A | -$0.11 | N/A | N/A | $80.67K | N/A | N/A | N/A | ||
| 11/12/25 | Q325 | -$0.17 | -$0.15 | -$0.02 | $130K | $227.17K | N/A |  | | Details | |
| 8/13/25 |
Q225 | -$0.06 | -$0.16 | +$0.10 | $6.3M | $67.8K | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.14 | -$0.14 | $0.00 | $130K | $79.6K | N/A | | | Details | |
| 5/12/25 |
Q125 | N/A | -$0.14 | N/A | N/A | $79.6K | N/A | N/A | N/A | ||
| 5/8/25 |
Q125 | N/A | -$0.14 | N/A | N/A | $79.6K | N/A | N/A | N/A | ||
| 3/11/25 |
Q424 | -$0.13 | -$0.17 | +$0.04 | $70K | $193.5K | N/A | | | Details | |
| 11/12/24 | Q324 | -$0.20 | -$0.21 | +$0.01 | $170K | $105.5K | N/A | | | Details |
